There's more to work than life.

Lily Collins and husband Charlie McDowell were over the moon after becoming parents in January 2025. The couple, who tied the ...

When she was happy, she was the happiest girl in the world, her family said. When she was sad ... health and suicide prevention, "Laps for Lilly,” a 5K run/walk is planned for May 3 beginning ...

Lily Vittayarukskul secured an internship at NASA by age 16, but her career path took an unexpected turn when her aunt — a cornerstone of her first-generation immigrant family — was diagnosed ...

March 12 (Reuters) - U.S. drugmakers Johnson & Johnson (JNJ.N), opens new tab and Eli Lilly (LLY.N), opens new ... to pay $132.5 million damages to US family 5:14 PM UTC · Updated ago Reuters ...

Gaddis, a Family Christian Academy transfer, scored 12 of her team-high 23 points in the first half, and a ferocious defensive effort helped No. 3 Woodlawn to a 61-43 semifinal win over No. 2 Edna ...

Eli Lilly is buying a new drug and lowering prices on an existing one. GLP-1 weight loss drug Zepbound is getting cheaper. This will make Lilly's product relatively more attractive, and help to ...

Eli Lilly and Co. Wednesday announced plans to build four pharmaceutical manufacturing sites in the United States, significantly boosting domestic medicine production and adding around 13,000 ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...

Lily Collins' husband Charlie McDowell shares an adorable new photo with their baby daughter Tove, saying it "doesn't get much better than this." ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...